Physician profile
Michelle Deschamplain
NPI 1952510299
$17,479.60
in general payments reported to CMS, 2019-2025
31 companies · $1,932 in 2025
The $1,932 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,961 · 2020: $399 · 2021: $1,106 · 2022: $1,258 · 2023: $1,891 · 2024: $7,934 · 2025: $1,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,419 · Food and Beverage: $4,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,418.58 |
| Food and Beverage | $4,338.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,734.24 | 2021-2025 | Abre, Hawkone, Turbohawk |
| Medtronic Vascular, INC. | $2,541.31 | 2019-2020 | |
| Penumbra, INC. | $1,673.04 | 2019-2025 | Indigo System, Penumbra System |
| Abbott Laboratories | $668.30 | 2021-2025 | Jeti, Esprit, Perclose Prostyle |
| Silk Road Medical, INC. | $623.59 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $556.42 | 2019-2021 | |
| Shockwave Medical, INC | $443.85 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $433.94 | 2019-2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Endologix LLC | $384.38 | 2022-2025 | Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $351.82 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Watchman Flx, Vercise |
| Cvrx, INC. | $238.32 | 2023-2024 | Barostim Neo System |
| Cagent Vascular INC | $126.47 | 2025 | Serrantor |
| Philips North America LLC | $125.54 | 2019-2025 | Labosys |
| Bard Peripheral Vascular, INC. | $91.37 | 2019 | |
| Smith+Nephew, INC. | $67.57 | 2022-2025 | Stravix, Grafix Pl, Renasys Touch |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $50.34 | 2019 | |
| Cardiva Medical, INC. | $47.02 | 2024 | Cardiva Vascade 6/7f Vcs, Optowire |
| Veryan Medical Incorporated | $38.00 | 2021 | |
| Kerecis Limited | $35.11 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Surmodics, INC. | $32.56 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Imperative Care, INC | $27.79 | 2024 | Symphony Catheter |
| Stryker Corporation | $25.08 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organogenesis INC. | $23.61 | 2022 | |
| Kci USA, INC. | $22.72 | 2022 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $21.48 | 2019 | |
| Ethicon US, LLC | $21.19 | 2022 | |
| Cardinal Health 200 LLC | $18.36 | 2021 | |
| Cardiovascular Systems INC. | $14.39 | 2022 | |
| Teleflex LLC | $14.18 | 2019 | |
| Getinge USA Sales, LLC | $13.91 | 2024 | Intergard |
| Convatec INC. | $13.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Deschamplain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.